Total Payments
$29,425
2024 Payments
$2,784
Companies
8
Transactions
34
Medicare Patients
1,881
Medicare Billing
$180,561
Payment Breakdown by Category
Other$29,250 (99.4%)
Food & Beverage$175.43 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,875 | 12 | 57.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,375 | 9 | 42.1% |
| Food and Beverage | $175.43 | 13 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organon Llc | $19,651 | 16 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $9,672 | 11 | $0 (2021) |
| GlaxoSmithKline, LLC. | $32.54 | 2 | $0 (2022) |
| Hologic Sales and Service, LLC | $16.22 | 1 | $0 (2024) |
| Agile Therapeutics, Inc. | $14.91 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $14.00 | 1 | $0 (2020) |
| Gilead Sciences, Inc. | $13.03 | 1 | $0 (2019) |
| Lilly USA, LLC | $12.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,784 | 4 | Organon Llc ($2,767) |
| 2022 | $9,647 | 9 | Organon LLC ($9,634) |
| 2021 | $15,540 | 14 | Merck Sharp & Dohme Corporation ($8,275) |
| 2020 | $1,430 | 5 | Merck Sharp & Dohme Corporation ($1,396) |
| 2019 | $13.03 | 1 | Gilead Sciences, Inc. ($13.03) |
| 2018 | $12.00 | 1 | Lilly USA, LLC ($12.00) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diagnostics | ||||||
| 03/28/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 01/19/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 01/12/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: ETONOGESTREL | ||||||
| 08/25/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 08/25/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 05/26/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 05/19/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 04/28/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: VACCINES | ||||||
| 02/28/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 02/25/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: ETONOGESTREL | ||||||
| 01/27/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 01/27/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 08/12/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 07/22/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 07/12/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/03/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/20/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/29/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/29/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/23/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: WOMENS HEALTH | ||||||
| 04/22/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/22/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 643 | 879 | $160,458 | $67,686 |
| 2022 | 12 | 584 | 757 | $123,945 | $52,634 |
| 2021 | 7 | 434 | 563 | $96,145 | $43,264 |
| 2020 | 7 | 220 | 271 | $46,850 | $16,977 |
Total Patients
1,881
Total Services
2,470
Medicare Billing
$180,561
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $37,448 | $18,454 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 275 | $47,300 | $15,046 | 31.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 53 | 53 | $28,090 | $14,906 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 93 | $22,599 | $7,408 | 32.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 27 | 27 | $7,101 | $3,469 | 48.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,770 | $2,236 | 46.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 25 | $3,654 | $1,788 | 48.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $2,744 | $1,401 | 51.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 25 | 25 | $2,168 | $953.00 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 32 | $1,850 | $915.20 | 49.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 17 | 17 | $1,360 | $648.04 | 47.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $744.00 | $377.64 | 50.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 105 | $630.00 | $83.29 | 13.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 134 | 134 | $31,144 | $16,634 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 237 | $34,989 | $11,891 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 112 | $23,731 | $8,101 | 34.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 24 | 24 | $12,720 | $6,395 | 50.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $5,036 | $2,175 | 43.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 29 | 29 | $4,060 | $1,851 | 45.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,477 | $1,756 | 50.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 42 | 42 | $3,360 | $1,426 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $2,128 | $1,024 | 48.1% |
| 0051A | Adm sarscv2 30mcg trs-sucr 1 | Office | 2022 | 21 | 21 | $1,680 | $755.46 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 21 | 21 | $1,176 | $565.74 | 48.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 74 | $444.00 | $60.06 | 13.5% |
About Dr. Michael Pendleton, MD
Dr. Michael Pendleton, MD is a Family Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922211556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Pendleton, MD has received a total of $29,425 in payments from pharmaceutical and medical device companies, with $2,784 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,875).
As a Medicare-enrolled provider, Pendleton has provided services to 1,881 Medicare beneficiaries, totaling 2,470 services with total Medicare billing of $180,561. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Louisville, KY
- Active Since 05/08/2007
- Last Updated 12/07/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922211556
Products in Payments
- NEXPLANON (Drug) $22,044
- Nexplanon (Drug) $7,250
- SHINGRIX (Biological) $32.54
- APTIMA (Device) $16.22
- Twirla (Drug) $14.91
- ROTATEQ (Biological) $14.84
- GARDASIL 9 (Biological) $14.37
- Vascepa (Drug) $14.00
- Truvada (Drug) $13.03
- TRULICITY (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Louisville
Christopher Rhyne, M.d, M.D
Family Medicine — Payments: $701,120
Family Medicine $701,120
Dr. Suraj Gathani, M.d, M.D
Family Medicine — Payments: $64,592
Family Medicine $64,592
Mandy Whitt, M.d, M.D
Family Medicine — Payments: $23,888
Family Medicine $23,888
Dr. James Wright, M.d, M.D
Family Medicine — Payments: $21,045
Family Medicine $21,045
Rosenberg Reyes, M.d, M.D
Family Medicine — Payments: $18,853
Family Medicine $18,853
Dr. Dennis Gray, M.d, M.D
Family Medicine — Payments: $14,723
Family Medicine $14,723